PPA
VKTX icon

Parametric Portfolio Associates’s Viking Therapeutics VKTX Stock Holding History

Parametric Portfolio Associates’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.1M Buy
365,354
+154,978
+74% +$556K ﹤0.01% 2737
2021
Q4 		$968K Sell
210,376
-99,560
-32% -$558K ﹤0.01% 2797
2021
Q3 		$1.95M Buy
309,936
+5,634
+2% +$34.8K ﹤0.01% 2458
2021
Q2 		$1.82M Buy
304,302
+44,730
+17% +$266K ﹤0.01% 2489
2021
Q1 		$1.64M Buy
259,572
+68,167
+36% +$480K ﹤0.01% 2909
2020
Q4 		$1.08M Buy
191,405
+47,327
+33% +$287K ﹤0.01% 3013
2020
Q3 		$839K Sell
144,078
-8,758
-6% -$60.3K ﹤0.01% 3028
2020
Q2 		$1.1M Buy
152,836
+22,487
+17% +$149K ﹤0.01% 2868
2020
Q1 		$610K Sell
130,349
-222,879
-63% -$1.37M ﹤0.01% 3058
2019
Q4 		$2.83M Buy
353,228
+255,596
+262% +$1.86M ﹤0.01% 2456
2019
Q3 		$672K Sell
97,632
-5,395
-5% -$40.1K ﹤0.01% 3229
2019
Q2 		$855K Sell
103,027
-42,171
-29% -$360K ﹤0.01% 3126
2019
Q1 		$1.44M Sell
145,198
-94,495
-39% -$791K ﹤0.01% 2835
2018
Q4 		$1.83M Sell
239,693
-8,542
-3% -$102K ﹤0.01% 2638
2018
Q3 		$4.32M Sell
248,235
-19,012
-7% -$226K ﹤0.01% 2144
2018
Q2 		$2.54M Buy
267,247
+196,151
+276% +$1.3M ﹤0.01% 2524
2018
Q1 		$311K Buy
+71,096
New +$393K ﹤0.01% 3561

Other funds holding VKTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Parametric Portfolio Associates's VKTX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Viking Therapeutics (VKTX) stake by 74% in Q1 2022, buying an estimated $556K and bringing the position to 365,354 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2737.

Parametric Portfolio Associates first reported a position in VKTX in Q1 2018 and has held it in 17 quarters since. The position peaked at $4.32M in Q3 2018. 140 funds tracked by Wall St. Rank hold VKTX as of Q1 2022.

  • Parametric Portfolio Associates held 365,354 shares of Viking Therapeutics worth $1.1M as of Q1 2022.
  • Parametric Portfolio Associates bought 154,978 Viking Therapeutics shares in Q1 2022, an estimated $556K.
  • Viking Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2737 holding.
  • Parametric Portfolio Associates first reported a position in Viking Therapeutics in Q1 2018 and has held it in 17 quarters since.
  • Parametric Portfolio Associates's Viking Therapeutics position peaked at $4.32M in Q3 2018.
  • 140 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.